AU2022361862A1 - Method for producing compound or pharmaceutically acceptable salt thereof - Google Patents
Method for producing compound or pharmaceutically acceptable salt thereof Download PDFInfo
- Publication number
- AU2022361862A1 AU2022361862A1 AU2022361862A AU2022361862A AU2022361862A1 AU 2022361862 A1 AU2022361862 A1 AU 2022361862A1 AU 2022361862 A AU2022361862 A AU 2022361862A AU 2022361862 A AU2022361862 A AU 2022361862A AU 2022361862 A1 AU2022361862 A1 AU 2022361862A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- crystal
- synthesizing
- reaction
- scheme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021164171 | 2021-10-05 | ||
| JP2021-164171 | 2021-10-05 | ||
| PCT/JP2022/037098 WO2023058645A1 (ja) | 2021-10-05 | 2022-10-04 | 化合物又はその薬学的に許容される塩の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022361862A1 true AU2022361862A1 (en) | 2024-04-18 |
Family
ID=85803498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022361862A Pending AU2022361862A1 (en) | 2021-10-05 | 2022-10-04 | Method for producing compound or pharmaceutically acceptable salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240262805A1 (https=) |
| EP (1) | EP4414362A4 (https=) |
| JP (1) | JPWO2023058645A1 (https=) |
| KR (1) | KR20240073943A (https=) |
| CN (1) | CN118055925A (https=) |
| AU (1) | AU2022361862A1 (https=) |
| CA (1) | CA3234498A1 (https=) |
| IL (1) | IL311879A (https=) |
| MX (1) | MX2024004049A (https=) |
| TW (1) | TW202330490A (https=) |
| WO (1) | WO2023058645A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116947658B (zh) * | 2023-07-28 | 2025-10-28 | 南通华祥医药科技有限公司 | 一种1-氨基-2-甲基-2-丙醇的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3269772B1 (en) * | 2015-03-10 | 2020-11-11 | Unimatec Co., Ltd. | Fluorine-containing boric acid/pvb composite |
| ES2856125T3 (es) | 2016-02-05 | 2021-09-27 | Ea Pharma Co Ltd | Derivado de sulfonamida y composición farmacéutica que contiene la misma |
| TW201731824A (zh) * | 2016-02-05 | 2017-09-16 | Ea Pharma Co Ltd | α４β７整合蛋白抑制劑 |
| JP2019031449A (ja) * | 2017-08-04 | 2019-02-28 | Ｅａファーマ株式会社 | スルホンアミド誘導体及びそれを含有する医薬組成物 |
-
2022
- 2022-10-04 WO PCT/JP2022/037098 patent/WO2023058645A1/ja not_active Ceased
- 2022-10-04 AU AU2022361862A patent/AU2022361862A1/en active Pending
- 2022-10-04 CA CA3234498A patent/CA3234498A1/en active Pending
- 2022-10-04 TW TW111137652A patent/TW202330490A/zh unknown
- 2022-10-04 EP EP22878513.5A patent/EP4414362A4/en active Pending
- 2022-10-04 JP JP2023552896A patent/JPWO2023058645A1/ja active Pending
- 2022-10-04 MX MX2024004049A patent/MX2024004049A/es unknown
- 2022-10-04 CN CN202280067043.4A patent/CN118055925A/zh active Pending
- 2022-10-04 KR KR1020247014478A patent/KR20240073943A/ko active Pending
- 2022-10-04 IL IL311879A patent/IL311879A/en unknown
-
2024
- 2024-04-02 US US18/624,295 patent/US20240262805A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4414362A4 (en) | 2025-09-03 |
| IL311879A (en) | 2024-06-01 |
| WO2023058645A1 (ja) | 2023-04-13 |
| CA3234498A1 (en) | 2023-04-13 |
| JPWO2023058645A1 (https=) | 2023-04-13 |
| KR20240073943A (ko) | 2024-05-27 |
| CN118055925A (zh) | 2024-05-17 |
| US20240262805A1 (en) | 2024-08-08 |
| MX2024004049A (es) | 2024-04-25 |
| TW202330490A (zh) | 2023-08-01 |
| EP4414362A1 (en) | 2024-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2859191C (en) | Process for preparation of optically active diamine derivative salt | |
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| WO2013180271A1 (ja) | 含フッ素アミノ酸のプロドラッグ | |
| CN107810189B (zh) | 用于制备氮芥衍生物的方法 | |
| CN105732765A (zh) | 丙肝药物维帕他韦的新合成方法 | |
| US20240262805A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| JP2002502378A (ja) | グアニジル化試薬 | |
| KR20190044652A (ko) | 인돌 카르복스아미드 화합물을 제조하는 방법 | |
| JP5983713B2 (ja) | 含フッ素アミノ酸のプロドラッグを含有する医薬 | |
| HK40111936A (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| CN116730861A (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体 | |
| HK40106397A (zh) | 化合物或其药学上允许的盐的制造方法 | |
| MXPA03000607A (es) | Procedimiento quimico. | |
| JPS5833877B2 (ja) | ユウキカゴウブツニカンスルカイリヨウ | |
| JPH078855B2 (ja) | スルホニウム化合物 | |
| JPH0363560B2 (https=) | ||
| CN112552374B (zh) | 一种肽酰胺类化合物及其中间体的制备方法 | |
| JP2013528214A (ja) | 結晶性エザチオスタット塩酸塩非溶媒和物ｄ型の調製 | |
| CA2720312A1 (en) | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds | |
| WO2026075272A1 (ja) | ２－オキソイミダゾールジペプチド又はその塩の製造方法及びその結晶形 | |
| CN120025261A (zh) | 一种2-氨酰基取代的l-苯丙氨酸的合成方法 | |
| JP2815438B2 (ja) | １，２―ビス（ニコチンアミド）プロパンの精製方法 | |
| CN120098068A (zh) | 一种醋酸地非法林的制备方法 | |
| JPH04234375A (ja) | 新規２，５−ジオキソピペラジン化合物及びその製造法 | |
| JPH0714906B2 (ja) | 保護アミノ酸の生成方法 |